122 related articles for article (PubMed ID: 37259027)
1. Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.
Duan C; Li K; Pan X; Wei Z; Xiao L
BMC Cancer; 2023 May; 23(1):489. PubMed ID: 37259027
[TBL] [Abstract][Full Text] [Related]
2. High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer.
Zhang S; Guo S; Li Z; Li D; Zhan Q
PeerJ; 2019; 7():e7946. PubMed ID: 31687275
[TBL] [Abstract][Full Text] [Related]
3. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
4. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ
Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441
[No Abstract] [Full Text] [Related]
5. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
6. Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries.
Elpek GO; Karaveli S; Simşek T; Keles N; Aksoy NH
APMIS; 2003 Apr; 111(4):523-30. PubMed ID: 12780528
[TBL] [Abstract][Full Text] [Related]
7. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
Chen Y; Bi F; An Y; Yang Q
J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
[TBL] [Abstract][Full Text] [Related]
8. Targeted blockade of HSP90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibition.
Gabbasov R; Benrubi ID; O'Brien SW; Krais JJ; Johnson N; Litwin S; Connolly DC
Cancer Biol Ther; 2019; 20(7):1035-1045. PubMed ID: 30929564
[TBL] [Abstract][Full Text] [Related]
9. Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.
Zhang D; Zou D; Deng Y; Yang L
J Ovarian Res; 2021 Sep; 14(1):120. PubMed ID: 34526089
[TBL] [Abstract][Full Text] [Related]
10. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer.
Kraus FBT; Topalov NE; Deuster E; Hysenaj I; Mayr D; Chelariu-Raicu A; Beyer S; Kolben T; Burges A; Mahner S; Trillsch F; Jeschke U; Czogalla B
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2501-2511. PubMed ID: 35751684
[TBL] [Abstract][Full Text] [Related]
12. Increased Expression of
Zou R; Xu H; Li F; Wang S; Zhu L
DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
[TBL] [Abstract][Full Text] [Related]
13. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
14. ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.
Hou L; Zhang X; Jiao Y; Li Y; Zhao Y; Guan Y; Liu Z
Medicine (Baltimore); 2019 May; 98(19):e15698. PubMed ID: 31083274
[TBL] [Abstract][Full Text] [Related]
15. Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer.
Lu W; Xie B; Tan G; Dai W; Ren J; Pervaz S; Li K; Li F; Wang Y; Wang M
Front Endocrinol (Lausanne); 2023; 14():1088944. PubMed ID: 36742380
[TBL] [Abstract][Full Text] [Related]
16. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
17. Cancer-testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis.
Lin L; Nong W; Luo B; Ge Y; Zeng X; Li F; Fan R; Zhang Q; Xie X
Immun Inflamm Dis; 2021 Dec; 9(4):1759-1770. PubMed ID: 34528758
[TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis to screen the key prognostic genes in ovarian cancer.
Li L; Cai S; Liu S; Feng H; Zhang J
J Ovarian Res; 2017 Apr; 10(1):27. PubMed ID: 28407786
[TBL] [Abstract][Full Text] [Related]
20. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
[No Abstract] [Full Text] [Related]
[Next] [New Search]